Meldungen sortieren nach Relevanz Meldungsdatum
Roche Diagnostics Purchases Microarray Instrument and Accessory Assets from BioMicro Systems
11.03.2010, Biotechnik, Roche Diagnostics GmbH
Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow....
Roche NimbleGen and Affymetrix Expand Licensing Agreement
13.03.2008, Biotechnik, Roche Diagnostics GmbH
Roche NimbleGen Inc., a company of Roche Applied Science, and Affymetrix Inc. announced that they have expanded the terms of the license to a number of Affymetrix...
imaGenes GmbH Adds Third Roche NimbleGen Certification to Service Portfolio for Comparative Genomic Hybridization
17.06.2010, Biotechnik, Roche Diagnostics GmbH
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce that imaGenes GmbH, located in Berlin, Germany, has passed the certification process to qualify...
Gene Biodesign Certified to Provide NimbleGen Array Services in Taiwan
12.10.2010, Biotechnik, Roche Diagnostics GmbH
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the...
Roche NimbleGen Introduces the MS 200 Microarray Scanner, Unleashing the Full Potential of NimbleGen Arrays
03.06.2009, Forschung und Entwicklung, Roche Diagnostics GmbH
Roche NimbleGen introduces a new high-resolution scanning instrument, the NimbleGen MS 200 Microarray Scanner. The MS 200 is the first scanner optimized to reveal...
Roche acquires NimbleGen to gain entry into high-growth research microarrray market
19.06.2007, Biotechnik, Roche Diagnostics GmbH
Roche and NimbleGen Systems Inc. today announced that they have signed a definitive agreement under which Roche will acquire 100% of NimbleGen, a privately held,...
CapitalBio Corporation Certified to Provide NimbleGen Array Services in China
11.02.2010, FirmenIntern, Roche Diagnostics GmbH
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announced today that Beijingbased genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified...
imaGenes GmbH Joins Roche NimbleGen's Certified Service Provider Program for ChIP-chip Analysis
15.12.2009, Biotechnik, Roche Diagnostics GmbH
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) has announced that imaGenes GmbH, a Berlinbased genomics & proteomics specialist, has achieved status as a Certified...
NewGene Ltd. Achieves Certification to Provide NimbleGen Sequence Capture Services in UK
30.11.2010, FirmenIntern, Roche Diagnostics GmbH
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announces that Newcastle-based genomic services provider NewGene Ltd. has officially become a Certified Service Provider...
Ambry Genetics Adds Certification of Roche NimbleGen CGH, DNA Methylation, Gene Expression, and ChIP-chip to Service Portfolio
19.04.2011, Biotechnik, Roche Diagnostics GmbH
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become...
BaseClear BV Certified to Provide NimbleGen Sequence Capture Services in the Netherlands
26.04.2011, FirmenIntern, Roche Diagnostics GmbH
Roche NimbleGen, a Roche (SIX: RO, ROG; OTCQX: RHHBY) Company announced today that the Netherlands-based genomic service provider BaseClear BV has officially joined...
The Roy J. Carver Center for Genomics (CCG) Achieves Certified Service Provider status for Roche NimbleGen microarrays
24.08.2011, Forschung und Entwicklung, Roche Diagnostics GmbH
In May 2011, The University of Iowa, Roy J. Carver Center for Genomics (CCG), entered into an agreement with Roche NimbleGen to provide microarray services through...
Ambry Genetics Becomes First Certified Service Provider in US for NimbleGen SeqCap EZ Exome
09.09.2010, FirmenIntern, Roche Diagnostics GmbH
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become...
Roche NimbleGen Launches 2.1 Million-Probe Arrays for the Detection of Chromosomal Aberrations and DNA Copy Number Variation
09.10.2008, Biotechnik, Roche Diagnostics GmbH
Roche NimbleGen, a company of Roche announced today the launch of comparative genomic hybridization (CGH) arrays and services for the high-resolution mapping of...
imaGenes GmbH Adds Certification of Roche NimbleGen DNA Methylation Analysis to Service Portfolio
25.02.2010, Biotechnik, Roche Diagnostics GmbH
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce that imaGenes GmbH, located in Berlin, Germany, has passed the certification process to qualify...
Ähnliche Keywords
Kategorien
- Biotechnik (57)
- Forschung und Entwicklung (33)
- FirmenIntern (13)
- Kooperationen / Fusionen (12)
- Medizintechnik (4)
Alle Kategorien



